Are there genetic determinants of olanzapine-induced agranulocytosis?
Felber
W
W
Naumann
R
R
Schuler
U
U
Fülle
M
M
Reuster
T
T
Garcia
K
K
Heilemann
H
H
D000380:Agranulocytosis / Q000097:blood / Q000139:chemically induced* / Q000235:genetics*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines; D015789:HLA-A2 Antigen / Q000235:genetics; D006801:Humans; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects / Q000031:analogs & derivatives*; D044469:Racial Groups
D014150:Antipsychotic Agents; D015789:HLA-A2 Antigen; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine